Key features and details
- Sheep polyclonal to Quinolone
- Suitable for: Competitive ELISA
- Reacts with: Species independent
- Isotype: IgG
Product nameAnti-Quinolone antibody
DescriptionSheep polyclonal to Quinolone
Specificity% cross reactivity : Norfloxacin : 100 Enrofloxacin : 288.9 Ciprofloxacin : 21.2 Ofloxacin : 110.5 Enoxacin : 74.2 Sarafloxacin : 56.8 Difloxacin : 52.1 Danofloxacin : 299.4 Flumequine : N/A Cinoxacin : N/A Nalidixic Acid : N/A Pipemidic Acid : N/A Oxolinic Acid : N/A
Tested applicationsSuitable for: Competitive ELISAmore details
Species reactivityReacts with: Species independent
Chemical/ Small Molecule corresponding to Quinolone conjugated to bovine serum albumin. Norfloxacin(N) conjugated to BSA.
General notesaccording to radox the concentration is 10.5 mg/m , dilution is 5mg/ml FP24/10/2007
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.20
Preservative: 0.09% Sodium azide
Constituents: 0.0536% PBS, 0.87% Sodium chloride
Concentration information loading...
The Abpromise guarantee
Our Abpromise guarantee covers the use of ab31123 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
RelevanceQuinolones and fluoroquinolones form a group of broad-spectrum antibiotics. They are related to nalidixic acid. Fluoroquinolone antibiotics are highly potent and at one time they were considered relatively safe. However, they can have potentially troublesome and irreversable side effects. Quinolones act by inhibiting the bacterial DNA gyrase and/or the topoisomerase IV enzyme. This way they inhibit DNA replication and act bacteriocidically. As such they are to be considered a chemotherapeutic agent as opposed to a true antibiotic as they prevent replication of the bacterial cell by interfering with the genetic replication of the bacterium.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab31123 has not yet been referenced specifically in any publications.